M&A Expansion Recent acquisitions of StrataDx and Bako Diagnostics indicate capacity expansion in pathology and lab services, creating cross-sell opportunities for integrated diagnostics, unified reporting platforms, and scalable testing programs with hospital systems and clinics.

Pharma Partnerships Strategic collaborations with Foundation Medicine and the launch of tests powered by Fulgent's platform open doors for pharma and biotech customers seeking companion diagnostics, trial support, and customized assay development.

Clinical Focus Focused offerings across oncology, anatomic pathology, infectious and rare diseases, and reproductive health align with hospitals, cancer centers, fertility clinics, and CROs, enabling expanded testing menus and bundled service options.

Quality Compliance CLIA certified, CAP accredited, and ISO 13485 compliant, Fulgent presents a strong quality and regulatory readiness proposition for regulated labs and healthcare providers.

Tech Integration A mature tech stack including AWS, Epic Beaker, and data platforms supports cloud analytics and data integration with EHRs and LIS, enabling opportunities for data management, analytics services, and customized reporting.